Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

被引:0
作者
Yoshida, N. [1 ]
Yabe, H. [2 ]
Kudo, K. [3 ]
Kobayashi, R. [4 ]
Yabe, M. [2 ]
Inoue, M. [5 ,6 ]
Miki, M. [7 ]
Sakamaki, H. [8 ]
Kawa, K. [9 ]
Suzuki, R. [10 ]
Kato, K. [1 ]
Watanabe, K. -I. [11 ]
Kojima, S. [12 ]
机构
[1] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[2] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 47011, Japan
[4] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan
[5] Osaka Med Ctr, Dept Hematol Oncol, Izumi, Japan
[6] Res Inst Maternal & Child Hlth, Izumi, Japan
[7] Hiroshima Univ, Dept Pediat, Grad Sch Biomed Sci, Hiroshima, Japan
[8] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan
[9] Japanese Red Cross Kinki Block Blood Ctr, Ibaraki, Japan
[10] Nagoya Univ, Dept HSCT Data Management & Biostat, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[11] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan
[12] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O151
引用
收藏
页码:S89 / S89
页数:1
相关论文
共 50 条
  • [31] Disease-specific conditioning regimen in hematopoietic stem cell transplantation for children with inherited bone marrow failure syndromes
    Luo, C. J.
    Li, Q.
    Luo, C.
    Wang, J.
    Li, B.
    Chen, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S432 - S432
  • [32] Reduced-intensity stem cell transplantation with fludarabine and melphalan for children with haematological malignancies
    Kato, K.
    Maeda, N.
    Kigasawa, H.
    Tsuchida, M.
    Kurosawa, H.
    Taga, T.
    Sano, H.
    Adachi, S.
    Horibe, K.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S292 - S292
  • [33] Fludarabine Melphalan Versus Fludarabine Treosulfan As Reduced Intensity Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplant - a Retrospective Analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh Arun
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin J.
    Khattry, Navin
    BLOOD, 2019, 134
  • [34] Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in Japan
    Sakaguchi, Hirotoshi
    Muramatsu, Hideki
    Hasegawa, Daiichiro
    Kudo, Kazuko
    Ishida, Hiroyuki
    Yoshida, Nao
    Koh, Katsuyoshi
    Noguchi, Maiko
    Shiba, Norio
    Tokimasa, Sadao
    Fukuda, Takhiro
    Goto, Hiroaki
    Miyamura, Takako
    Nakazawa, Yozo
    Hashii, Yoshiko
    Inoue, Masami
    Atsuta, Yoshiko
    PEDIATRIC BLOOD & CANCER, 2019, 66 (01)
  • [35] Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure
    Quintero, Victor
    Bueno-Sanchez, David
    Mozo-Del-Castillo, Yasmina
    Urtasun-Erburu, Andrea
    Sisinni, Luisa
    Lopez-Duarte, Monica
    Perez-Hurtado, Jose Maria
    Fuster, Jose Luis
    Gonzalez-Vicent, Marta
    Perez-Martinez, Antonio
    Diaz-de-Heredia, Cristina
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (10): : e1 - e6
  • [36] Improved outcome of stem cell transplantation in children with congenital bone marrow failure syndromes - the use of fludarabine with low-dose cyclophosphamide
    George, B.
    Mathews, V.
    Ahmed, R.
    Abraham, A.
    Srivastava, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S383 - S384
  • [37] Fludarabine-based Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in a Pediatric Patient With Bone Marrow Failure Syndrome Type 3
    Barhoom, Dima
    Mohseni, Rashin
    Behfar, Maryam
    Hamidieh, Amir A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (08) : E1050 - E1052
  • [38] BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN AS CONDITIONING REGIMEN FOR BONE-MARROW TRANSPLANTATION IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES
    LOCATELLI, F
    PESSION, A
    BONETTI, F
    MASERATI, E
    PRETE, L
    PEDRAZZOLI, P
    ZECCA, M
    PRETE, A
    PAOLUCCI, P
    CAZZOLA, M
    LEUKEMIA, 1994, 8 (05) : 844 - 849
  • [39] Matched Cohort Analysis of Allogeneic Hematopoietic Cell Transplantation (HCT) with Total Marrow Irradiation/Fludarabine/Melphalan (TFM) Versus Fludarabine/Melphalan (FM) Conditioning for Acute Leukemia
    Rosenthal, Joseph
    Wong, Jefrrey
    Stein, Anthony Selwyn
    Stiller, Tracy
    Palmer, Joycelynne
    Forman, Stephen J.
    BLOOD, 2012, 120 (21)
  • [40] Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: Preliminary results
    Terenzi, A
    Aristei, C
    Aversa, F
    Perruccio, K
    Chionne, F
    Raymondi, C
    Latini, P
    Martelli, MF
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3101 - 3101